FDA authorizes Pfizer booster for 12 to 15-year-olds
The FDA has authorized the Pfizer–BioNTech COVID-19 vaccine as a booster for children aged 12 to 15, marking the first such authorization globally for this age group.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthFDA authorizes Pfizer booster for 12 to 15-year-olds
Sign in or subscribeBrowse free archive reportsThe FDA has authorized the Pfizer–BioNTech COVID-19 vaccine as a booster for children aged 12 to 15, marking the first such authorization globally for this age group.